<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="58154">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02348970</url>
  </required_header>
  <id_info>
    <org_study_id>ONI-003</org_study_id>
    <nct_id>NCT02348970</nct_id>
  </id_info>
  <brief_title>Efficacy and Compliance of the Mandibular Advancement Devices ONIRIS® vs. Custom Made Devices</brief_title>
  <acronym>IRIS</acronym>
  <official_title>Multicenters, Randomised Clinical Trial, to Evaluate Efficacy and Compliance of Mandibular Advancement Devices ONIRIS® vs. Laboratory Devices TALI in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ONIRIS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ONIRIS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy (non-inferiority) in terms of response between patients using
      custom fitted mandibular advancement devices ONIRIS® and patient using laboratory custom
      made devices TALI, after 2 months of use. Sleeping tests were performed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Open, non-inferiority, controlled and rndomised clinical trial. Six months of inclusion.
      Each included patient will be followed during 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the efficacity (non-inferiority) in terms of response between patients using mandibular advancement devices ONIRIS® and patient using devices produced in a laboratoryTALI after 2 months of use.</measure>
    <time_frame>2 monthes of use</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">204</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>mandibular advancement devices ONIRIS®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will use the mandibular advancement devices ONIRIS®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laboratory devices TALI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will use the laboratory devices TALI</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ONIRIS®</intervention_name>
    <description>sleeping test</description>
    <arm_group_label>mandibular advancement devices ONIRIS®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TALI</intervention_name>
    <description>sleeping test</description>
    <arm_group_label>laboratory devices TALI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with severe syndrome of obstructive sleep apnea and hypopneas refusing or
             withdrawal from continuous positive pression ventilation

          -  no dental, paro-dental or articular contraindication

          -  patients never treated by mandibular advancement devices

        Exclusion Criteria:

          -  severe psychiatric or neuromuscular disorders appreciated by the investigator

          -  more than 20% of apneas and central hypoapneas

          -  severe syndrome of obstructive sleep apnea and hypopneas with IAH &gt; 30% associated
             with another sleeping pathology

          -  BMI &gt; 30kg/m2

          -  patient with an uncontrollable nausea reflex

          -  epileptic patients

          -  pregnant patients

          -  patient without written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>RAYMOND Nathalie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Bel Air</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elsa LLOBET-MERKLING</last_name>
    <phone>0613861174</phone>
    <phone_ext>+33</phone_ext>
    <email>e.llobetmerkling@euraxipharma.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinique Bel-Air</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>RAYMOND , MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Polyclinique Saint Privat</name>
      <address>
        <city>Boujan sur Libron</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JAFFUEL , MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>La Tronche</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>TAMISIER , MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital André Mignot</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78157</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SMITH , MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Practice</name>
      <address>
        <city>Les Pavillons sous Bois</city>
        <zip>93320</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AISENBERG , MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Practice</name>
      <address>
        <city>Maisons-Alfort</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MALLET , MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>EL BAKKOURI , MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Practice</name>
      <address>
        <city>Perpignan</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LACAZE , MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Cardiologique du Nord</name>
      <address>
        <city>St Denis</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 22, 2016</lastchanged_date>
  <firstreceived_date>January 12, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mandibular advancement devices ONIRIS®</keyword>
  <keyword>obstructive sleep apnea and hypopneas</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
